Your browser doesn't support javascript.
loading
BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4.
Suzuki, Momoko; Abe, Akihiro; Imagama, Shizuka; Nomura, Yuka; Tanizaki, Ryohei; Minami, Yosuke; Hayakawa, Fumihiko; Ito, Yoshie; Katsumi, Akira; Yamamoto, Kazuhito; Emi, Nobuhiko; Kiyoi, Hitoshi; Naoe, Tomoki.
Affiliation
  • Suzuki M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Eur J Haematol ; 84(3): 229-38, 2010 Mar.
Article in En | MEDLINE | ID: mdl-20002159

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Fusion Proteins, bcr-abl / Ras Proteins / Drug Resistance, Neoplasm / Receptor, EphB4 / Protein Kinase Inhibitors / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Neoplasm Proteins Limits: Female / Humans / Middle aged Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2010 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Fusion Proteins, bcr-abl / Ras Proteins / Drug Resistance, Neoplasm / Receptor, EphB4 / Protein Kinase Inhibitors / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Neoplasm Proteins Limits: Female / Humans / Middle aged Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2010 Type: Article Affiliation country: Japan